GET THE APP

About

Dec 05-06, 2022    Chicago, USA

International Conference on Immunology Allergic Diseases

Immunology 2022 takes a great privilege to welcome you to the “International Conference on Immunology & Allergic Diseases” going to be held during December 5-6, 2022 at Singapore city, Singapore. Immunology 2022 hosted and organized by Longdom Conferences provides an international forum for the exchange of information in a wide arena of branches of Immunology .The theme of the Conference is “Novel Biologicals for the Treatment of Allergic Diseases and Immunology ".

This theme enables participants to develop their insight into their own research field while expanding their perspectives, providing sound knowledge to highly eminent professionals and young researchers. It melds brief keynote presentations, speaker talks, exhibition, symposia, and workshops. Immunology 2022 which will be visited by all the prestigious immunologists, Allergists, Physicians, postgraduates, affiliations, business meanders under a solitary rooftop. Immunology 2022 deals with a course of action of 1000+ global events thorough of 300+ Conferences, 500+ upcoming and previous symposiums and workshops in USA, Europe and Asia with sponsorship from 1000 more sensible social requests and disseminates 700+ open get to journals which contains more than 30000 unmistakable personalities, reputed specialists as article board people.

SESSIONS AND TRACKS-

TRACK 1- BIOMARKERS

Various biomarkers have been developed by omics technologies, some of which lead to a better classification of distinct phenotypes or endotypes.  The introduction of biologicals to clinical practice increases the need for biomarkers for patient selection, prediction of outcomes and monitoring, to allow for an adequate choice of the duration of these costly and long-lasting therapies. Modern health care requires a proactive and individualized response to diseases, combining precision diagnosis and personalized treatment.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 2- ALLERGY AND CLINICAL IMMUNOLOGY

The potential for precision medicine in food allergy, drug allergy, and anaphylaxis under the auspices of the PRACTALL collaboration platform. PRACTALL is a joint effort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology, which aims to synchronize the European and American approaches to allergy care. Progress has been made in discovery of biomarkers to guide a precision medicine approach to treatment of food and drug allergy, but further validation and quantification of these biomarkers are needed to allow their translation into practice in the clinical management of allergic disease.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 3- ALLERGY IMMUNOTHERAPY

Allergy immunotherapy (AIT) is an effective treatment for allergic asthma and rhinitis, as well as venom-induced anaphylaxis. In addition to reducing symptoms, AIT can change the course of allergic disease and induce allergen-specific immune tolerance. In current clinical practice immunotherapy is delivered either subcutaneously or sublingually; some allergens, such as grass pollen, can be delivered through either route, whereas others, such as venoms, are only delivered subcutaneously. Both subcutaneous and sublingual immunotherapy appear to have a duration of efficacy of up to 12 years, and both can prevent the development of asthma and new allergen sensitivities.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 4- SUBLINGUAL IMMUNOTHERAPY IN ALLERGIC RHINITIS CHILDREN

Sublingual immunotherapy (SLIT) had good effectiveness for children with allergic rhinitis (AR). However, no studies explored the effect of persistent allergen exposure on SLIT treatment. Coronavirus disease 2019 (COVID-19) restricts outdoor activities of children significantly. We aimed to evaluate the effectiveness of SLIT during this special period. results suggest that continuous HDM exposure reduced the effectiveness of SLIT, whereas effective reduction of HDM levels by frequent bed cleaning will be helpful during the SLIT treatment.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 5- MICROBIOME IN ALLERGIC DISEASE

PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and immunology. PRACTALL 2017 is focused on what has been established regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allergy. This is complemented by outlining important knowledge gaps regarding its role in allergic disease and delineating strategies necessary to fill these gaps. In addition, a review of progress in approaches used to manipulate the microbiome will be addressed, identifying what has and has not worked to serve as a baseline for future directions to intervene in allergic disease development, progression, or both.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 6- PRIORITIES IN RHINITIS AND RHINOSINUSITIS

The first European Rhinology Research Forum organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) was held in the Royal Academy of Medicine in Brussels on 17th and 18th November 2016, in collaboration with the European Rhinologic Society (ERS) and the Global Allergy and Asthma European Network (GA2LEN). This is thoroughly integrated in the context of Precision Medicine (PM), with personalized care, prediction of success of treatment, participation of the patient and prevention of disease as key principles for improving current clinical practices. This report provides a concise summary of the outcomes of the brainstorming sessions of the European Rhinology Research Forum 2016.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 7- FROM RHINITIS PHENOTYPE TO DISEASE SPECTRUM

Local respiratory allergy (LRA) is defined by the negativity of atopy tests, a clinical history suggestive of airway allergy and a positive response to the nasal and/or bronchial allergen challenge. The clinical spectrum of LRA is comprised of three conditions: local allergic rhinitis (LAR) and local allergic asthma in non-atopic patients, and dual allergic rhinitis (coexistence of allergic rhinitis and LAR) in atopic individuals. LRA is an independent disease phenotype not progressing to atopy over time, but naturally evolving to the clinical worsening and the onset of comorbidities. Published data suggests that LRA is mediated through the mucosal synthesis of allergen-specific (s)IgE, which binds to FcϵRI on resident mast cells, and in >50% of cases traffics to the blood stream to sensitize circulating basophils.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

TRACK 8- IMMUNOTHERAPY FOR PAEDIATRIC RESPIRATORY ALLERGY

Allergic respiratory diseases are major health problems in paediatric population due their high level of prevalence and chronicity, and to their relevance in the costs and quality of life. One of the most important risk factors for the development of airway diseases in children and adolescents is atopy. The mainstays for the treatment of these diseases are avoiding allergens, controlling symptoms, and preventing them through sustained desensitization by allergen immunotherapy (AIT). In addition, it is considered the only treatment that can influence the natural course of the disease by targeting the cause of the allergic inflammatory response. The aim of this publication is to reflect the advances of AIT in the diagnosis and treatment of allergic respiratory diseases in children and adolescents reviewing articles published since 2000, establishing evidence categories to support the strength of the recommendations based on evidence.

Related Conferences:- Immunology Conferences | Allergic Diseases Symposium | Immunology and Allergic Diseases conclave | Immunology events | Allergic diseases summit | Allergic Diseases meetings | Allergic Diseases eventsImmunology Meetings | Immunology symposium

                                                                                 MARKET ANALYSIS OF IMMUNOLOGY AND ALLERGIC DISEASES

The 1st International Conference on Immunology and Allergic Disesases to be held at Chicago, USA. The Immunology and Allergic Disesases is becoming very well abroad in countries, for example, North America, Europe, Asia pacific, South America, Middle East and Africa. The worldwide sanitation testing market is gauge to esteem at USD 25.9 billion developing at a CAGR of 9.6% during the estimate time of 2019-2024.

Existing market players operating in the global immunology market are focusing on constant innovations and up-gradation of their product portfolio with new and efficient product offerings for better treatment outcomes for the patients. One of the primary reasons for the growth of the global market is the increasing incidence of immunological and autoimmune diseases. Rise in awareness regarding immunological diseases in both developing and developed nations, and the higher prevalence of immunological disorders due to environmental factors, thus propelling the of the global immunology market growth. This coupled with, increasing investments by major players in research and development activities are also boosting the growth of the market globally.

GLOBAL UNIVERSITIES:-

  • Roosevelt University
  • The University of Chicago
  • The University of Chicago Booth School of Business
  • University of Illinois at Urbana-Champaign
  • The University of Chicago Pritzker School of Medicine

 

RESEARCH CENTRES:-

  • Chicago Research Center Inc
  • McCrone Research Institute
  • UIC - Learning Sciences Research Institute LSRI
  • Institute for Health Research & Policy
  • Institute for Health Research & Policy

 

RELATED ASSOCIATIONS AND SOCIETIES:-

  • Society of American Archivists
  • Society For Information Management
  • The Decalogue Society of Lawyers
  • Ausarauset Society Chicago Rgn
  [email protected]
  [email protected]
  [email protected]
Speakers Interview